ACRS · Aclaris Therapeutics, Inc.

$5.78 -0.08 (-1.37%) At close · Aug 14

Market Cap

$850.81M

147.20M

Press releases and events scraped from the company's investor relations website. Past events open our own call or event page when we host one; otherwise listings link to the original source.

Past events

Date	Event	Type
2026-06-04	Jefferies Global Healthcare Conference	Conference
2026-05-14	Bank of America 2026 Global Healthcare Conference	Conference
2026-04-28	Earnings conference call (announced in 8-K)	Earnings call
2026-04-28	Aclaris Clinical Program Update	Event
2026-04-14	H.C. Wainwright 4th Annual Inflammatory Skin Disease Virtual Conference	Conference
2026-03-10	Leerink Global Healthcare Conference	Conference
2026-02-26	Oppenheimer 36th Annual Healthcare Life Sciences Conference	Conference
2026-02-12	Guggenheim Emerging Outlook: Biotech Summit 2026	Event
2026-01-06	Earnings conference call (announced in 8-K)	Earnings call
2026-01-06	Aclaris ATI-052 Interim Phase 1a Clinical Trial Results	Event
2025-12-02	Piper Sandler 37th Annual Healthcare Conference	Conference
2025-11-17	Jefferies Global Healthcare Conference	Conference
2025-11-12	Stifel 2025 Healthcare Conference	Conference
2025-11-12	Guggenheim 2nd Annual Healthcare Conference	Conference
2025-10-14	2025 R&D Day	Event
2025-09-09	H.C. Wainwright 27th Annual Global Investment Conference	Conference
2025-09-03	Cantor Global Healthcare Conference	Conference
2025-07-29	Aclaris Therapeutics ATI-2138 Phase 2a Results and ITK Franchise Update	Event
2025-06-30	H.C. Wainwright Inflammation & Immunology Virtual Conference	Conference
2025-06-11	46th Annual Goldman Sachs Global Healthcare Conference	Conference
2025-06-04	Jefferies Global Healthcare Conference	Conference

Source: https://investor.aclaristx.com/

Key facts CIK 1557746 CUSIP 00461U105 13F (30d) 144 filings 142 filers Visit website Investor relations